)
Gerresheimer (GXI) investor relations material
Gerresheimer Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Extensive compliance and forensic investigations concluded, resulting in a restatement of 2024 financials and a clean, audited 2025 annual report.
Management focus on governance, transformation, and disciplined execution, with new executive board and broad creditor support via stabilization agreement.
Strategic priorities include the sale of Centor and comprehensive debt refinancing, both targeted for completion in 2026.
Gerresheimer Transformation Offensive (GTO/gto) launched, targeting operational and cash excellence, fast payback, and improved profitability.
Financial highlights
2024 restated revenue down 2% (€45m) and EBITDA down 7% (€31m) due to corrections from investigations; 2025 impairments totaled €258m.
2025 revenue at €2.3bn, up 17% year-over-year, mainly from Bormioli acquisition; organic/legacy growth flat.
Adjusted EBITDA margin for 2025 at 16.8%, within guidance; adjusted EBITDA down 1% year-over-year to €384m.
EPS at -€1.65, reflecting significant one-time items and restructuring challenges.
Free cash flow before M&A at -€86m, with CapEx of €295m (one-third base, two-thirds growth).
Outlook and guidance
2026 revenue expected in the lower half of €2.3bn–€2.4bn range due to economic headwinds, project delays, and operational challenges.
Adjusted EBITDA margin guided at 17%–18%; free cash flow before M&A between -€50m and -€100m.
GTO/gto expected to contribute €10m–€20m EBITDA in 2026, with midterm targets of 200–400bps profitability improvement.
Acceleration of revenue growth and margin improvement anticipated in the second half of the year.
- Q2 2024 showed resilient results, strong Plastics & Devices, and a major pharma acquisition.GXI
Q2 20243 Feb 2026 - 2024 guidance cut as vial demand lags and US plant flooding impacts results.GXI
Q3 2024 TU20 Jan 2026 - Strong Q4 growth and Bormioli integration drive robust 2025 outlook and margin expansion.GXI
Q4 202410 Dec 2025 - Sustainable growth fueled by innovation, digitalization, and global capacity expansion.GXI
Investor Presentation7 Dec 2025 - Revenue up 11.6% on Bormioli Pharma deal, but net income negative amid higher debt.GXI
Q1 202529 Nov 2025 - 2025 outlook and dividend cut as weak H1 demand prompts lower growth and margin guidance.GXI
Q2 2025 TU24 Nov 2025 - Revenue up 19.6% with Bormioli Pharma, but margins and 2025 outlook were revised downward.GXI
Q2 202516 Nov 2025 - Organic revenue and EBITDA fell, guidance was cut, and transformation actions were launched.GXI
Q3 202522 Oct 2025 - Guidance cut after weak Q3 and 9M, with organic revenue and EBITDA both down year-over-year.GXI
Q3 2025 TU10 Oct 2025
Next Gerresheimer earnings date
Next Gerresheimer earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage